Number of employees
4760
Annual revenue
$975000000
In addition to the acquisition of Alpharma's human generics business, Actavis acquired New Jersey- based Amide Pharmaceuticals in May 2005, giving the company a strong presence in the US. Over one third of 2006 Group revenues are expected to be generated in this key market. In addition, Actavis will gain a local presence for its own-label products in the largest European generic pharmaceutical markets, Germany and the UK, as well as enhancing its position in Scandinavia, the Netherlands, Portugal and other European countries.